We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 3,863 results
  1. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation

    Background

    For non-functioning pancreatic neuroendocrine tumors (pNETs) ≤ 20 mm, most guidelines consider follow-up observations as an option;...

    Yuki Kawasaki, Susumu Hijioka, ... Takuji Okusaka in Journal of Gastroenterology
    Article 08 May 2023
  2. Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1)

    Luigi Camera, Francesca Boccadifuoco, ... Arturo Brunetti in Endocrine
    Article 26 April 2023
  3. Malignant Chest Wall Tumors: Complex Defects and Their Management—A Review of 181 Cases

    Background

    Chest wall tumors are a heterogeneous group of tumors that are managed by surgeons from diverse specialties. Due to their rarity, there is...

    Jyoti Sharma, S. V. S. Deo, ... D. N. Sharma in Annals of Surgical Oncology
    Article 28 December 2023
  4. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation

    Objective

    To investigate the prognostic factors of patients with pancreatic neuroendocrine tumor (pNETs) after surgical resection, and to analyze the...

    Junzhang Chen, Yongyu Yang, ... He** Kan in World Journal of Surgical Oncology
    Article Open access 12 January 2021
  5. Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view

    Insulinoma is a rare pancreatic neuroendocrine tumor (pNET) potentially associated with severe hypoglycaemic crisis. The great majority of these...

    Valeria Tovazzi, Vittorio D. Ferrari, ... Alfredo Berruti in Endocrine
    Article 02 June 2020
  6. Robotic versus laparoscopic distal pancreatectomy in obese patients

    Background

    Although robotic distal pancreatectomy (RDP) has a lower conversion rate to open surgery and causes less blood loss than laparoscopic...

    Fabio Ausania, Filippo Landi, ... Pier C. Giulianotti in Surgical Endoscopy
    Article Open access 15 September 2023
  7. Primary pancreatic Ewing sarcoma with metastases on FDG PET/CT

    Background

    Ewing sarcoma (ES) is a highly aggressive malignant tumor most commonly affecting long bones. Extraskeletal Ewing sarcoma (EES) is a...

    Man Mohan Singh, Shashwat Verma, ... Akanksha Sharma in Egyptian Journal of Radiology and Nuclear Medicine
    Article Open access 06 September 2023
  8. Multiple drugs

    Article 25 March 2023
  9. Primitive Neuroectodermal Tumour of the Larynx: A Rare Case Report

    Ewing’s sarcoma/primitive neuroectodermal tumour is a malignant small round blue cell tumour of neuroectodermal origin that affects bones and soft...

    Swapnil Kaushal, Fernandes Ellerhea, ... Desai Abhineet in Indian Journal of Surgical Oncology
    Article 27 May 2024
  10. Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons

    Purpose

    Neuroendocrine neoplasms (NENs) are a heterogeneous group of malignancies originating from cells with a neuroendocrine phenotype. The complex...

    Roberta Modica, Anna La Salvia, ... Antongiulio Faggiano in Endocrine
    Article Open access 20 March 2024
  11. Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes

    Background

    Few epidemiological studies of pediatric central nervous system (CNS) tumors have been performed using data from Southeast Asian national...

    Bunchoo Pongtanakul, Nongnuch Sirachainan, ... Suradej Hongeng in Journal of Neuro-Oncology
    Article 24 July 2020
  12. Desmoplastic small round cell tumor of the kidney: a case report

    Background

    Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive neoplasm seen in children and young adults, usually manifested by...

    Dilek Ertoy Baydar, Ayse Armutlu, ... Yarkin Kamil Yakupoglu in Diagnostic Pathology
    Article Open access 23 July 2020
  13. Two-step osteotomy/discectomy through cannulated screw (TOCS) technique for en bloc resection of spine tumor: surgical technique and preliminary results

    Purpose

    We have developed a novel technique for osteotomy/discectomy during en bloc resection of spine tumors named two-step osteotomy/discectomy...

    Ran Wei, Kunkun Sun, ... **aodong Tang in European Spine Journal
    Article 28 February 2024
  14. GEP-NET radiomics: a systematic review and radiomics quality score assessment

    Objective

    The number of radiomics studies in gastroenteropancreatic neuroendocrine tumours (GEP-NETs) is rapidly increasing. This systematic review...

    Femke C. R. Staal, Else A. Aalbersberg, ... Monique Maas in European Radiology
    Article 26 July 2022
  15. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)

    Background

    Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant disorder caused by pathogenic variants in either the TSC1 or TSC2 ...

    Matthias Sauter, Elena Belousova, ... Regina Trollmann in Orphanet Journal of Rare Diseases
    Article Open access 06 July 2021
  16. Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database

    Objective

    To investigate outcomes after surgery for rare brain tumors using the Swedish Brain Tumor Registry (SBTR).

    Methods

    This is a nationwide...

    Jiri Bartek Jr., Sanjay Dhawan, ... Asgeir Store Jakola in Journal of Neuro-Oncology
    Article Open access 19 May 2020
  17. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group

    Background

    Pancreatic neuroendocrine tumors (PNETs) are often indolent; however, identifying patients at risk for rapidly progressing variants is...

    Jordan J. Baechle, Paula Marincola Smith, ... Kamran Idrees in Annals of Surgical Oncology
    Article 23 April 2020
  18. Multiple drugs

    Article 06 July 2024
  19. Endokrine Onkologie

    Background

    In the management of solid tumours, routine concepts are increasingly being transformed into individualized patient treatment. Endocrine...

    Kerstin Lorenz in Die Innere Medizin
    Article 18 June 2024
Did you find what you were looking for? Share feedback.